Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer ; volume:11 ; number:1 ; day:21 ; month:11 ; year:2011 ; pages:1-7 ; date:12.2011
BMC cancer ; 11, Heft 1 (21.11.2011), 1-7, 12.2011
- Creator
-
Hwang, Jun-Eul
- Contributor
-
Kim, Ha-Na
Kim, Dae-Eun
Choi, Hyun-Jung
Jung, Sung-Hoon
Shim, Hyun-Jeong
Bae, Woo-Kyun
Hwang, Eu-Chang
Cho, Sang-Hee
Chung, Ik-Joo
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-11-489
- URN
-
urn:nbn:de:1111-2016030364955
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hwang, Jun-Eul
- Kim, Ha-Na
- Kim, Dae-Eun
- Choi, Hyun-Jung
- Jung, Sung-Hoon
- Shim, Hyun-Jeong
- Bae, Woo-Kyun
- Hwang, Eu-Chang
- Cho, Sang-Hee
- Chung, Ik-Joo
- SpringerLink (Online service)
Other Objects (12)
Prognostic significance of platelet–lymphocyte ratio in patients receiving first-line tyrosine kinase inhibitors for metastatic renal cell cancer
Prognostic potential of standard laboratory parameters in patients with metastatic renal cell cancer receiving first-line immunotherapy
Quality of life assessment in patients with metastatic colorectal cancer receiving maintenance therapy after first-line induction treatment
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment
Prognostic factors for renal function deterioration during palliative first-line chemotherapy for metastatic colorectal cancer: a retrospective study
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Podcast to Discuss Therapy Management for Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Axitinib Plus an Immune Checkpoint Inhibitor
Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502
Treatment Patterns in US Patients Receiving First-Line and Second-Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma in the Real World
Long-term virological outcome in children receiving first-line antiretroviral therapy
Predictive significance of FGFR4 p.G388R polymorphism in metastatic colorectal cancer patients receiving trifluridine/tipiracil (TAS-102) treatment
Targeted palliative radionuclide therapy for metastatic bone pain
Prognostic significance of platelet–lymphocyte ratio in patients receiving first-line tyrosine kinase inhibitors for metastatic renal cell cancer
Prognostic potential of standard laboratory parameters in patients with metastatic renal cell cancer receiving first-line immunotherapy
Quality of life assessment in patients with metastatic colorectal cancer receiving maintenance therapy after first-line induction treatment
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment
Prognostic factors for renal function deterioration during palliative first-line chemotherapy for metastatic colorectal cancer: a retrospective study
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Podcast to Discuss Therapy Management for Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Axitinib Plus an Immune Checkpoint Inhibitor
Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502
Treatment Patterns in US Patients Receiving First-Line and Second-Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma in the Real World
Long-term virological outcome in children receiving first-line antiretroviral therapy
Predictive significance of FGFR4 p.G388R polymorphism in metastatic colorectal cancer patients receiving trifluridine/tipiracil (TAS-102) treatment
Targeted palliative radionuclide therapy for metastatic bone pain
Prognostic significance of platelet–lymphocyte ratio in patients receiving first-line tyrosine kinase inhibitors for metastatic renal cell cancer
Prognostic potential of standard laboratory parameters in patients with metastatic renal cell cancer receiving first-line immunotherapy
Quality of life assessment in patients with metastatic colorectal cancer receiving maintenance therapy after first-line induction treatment
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment
Prognostic factors for renal function deterioration during palliative first-line chemotherapy for metastatic colorectal cancer: a retrospective study
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Podcast to Discuss Therapy Management for Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Axitinib Plus an Immune Checkpoint Inhibitor
Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502
Treatment Patterns in US Patients Receiving First-Line and Second-Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma in the Real World
Long-term virological outcome in children receiving first-line antiretroviral therapy
Predictive significance of FGFR4 p.G388R polymorphism in metastatic colorectal cancer patients receiving trifluridine/tipiracil (TAS-102) treatment